FDA Fast Track, ODD, and RPDD Designations for FBX-101 Gene Therapy for Patients with Krabbe Disease
FDA Clearance of Investigational New Drug for Patients with Krabbe Disease
United Leukodystrophy Foundation
RESKUE Trial for Patients with Krabbe Disease
